|
US7868204B2
(en)
*
|
2001-09-14 |
2011-01-11 |
Methylgene Inc. |
Inhibitors of histone deacetylase
|
|
MXPA04002397A
(es)
|
2001-09-14 |
2004-12-02 |
Methylgene Inc |
Inhibidores de histona deacetilasa.
|
|
US6897220B2
(en)
*
|
2001-09-14 |
2005-05-24 |
Methylgene, Inc. |
Inhibitors of histone deacetylase
|
|
KR100875362B1
(ko)
|
2002-02-05 |
2008-12-22 |
아스텔라스세이야쿠 가부시키가이샤 |
2,4,6-트리아미노-1,3,5-트리아진 유도체
|
|
TWI319387B
(en)
*
|
2002-04-05 |
2010-01-11 |
Astrazeneca Ab |
Benzamide derivatives
|
|
GB0209715D0
(en)
*
|
2002-04-27 |
2002-06-05 |
Astrazeneca Ab |
Chemical compounds
|
|
US7154002B1
(en)
|
2002-10-08 |
2006-12-26 |
Takeda San Diego, Inc. |
Histone deacetylase inhibitors
|
|
US7250514B1
(en)
|
2002-10-21 |
2007-07-31 |
Takeda San Diego, Inc. |
Histone deacetylase inhibitors
|
|
US7351719B2
(en)
|
2002-10-31 |
2008-04-01 |
Boehringer Ingelheim Pharma Gmbh & Co. Kg |
Amide compounds having MCH-antagonistic activity and medicaments comprising these compounds
|
|
US7375228B2
(en)
|
2003-03-17 |
2008-05-20 |
Takeda San Diego, Inc. |
Histone deacetylase inhibitors
|
|
PT1636228E
(pt)
|
2003-05-23 |
2009-02-02 |
Aeterna Zentaris Gmbh |
Novas piridopirazinas e sua utilização como moduladores de cinases
|
|
DE10323345A1
(de)
*
|
2003-05-23 |
2004-12-16 |
Zentaris Gmbh |
Neue Pyridopyrazine und deren Verwendung als Kinase-Inhibitoren
|
|
NZ544756A
(en)
|
2003-07-22 |
2009-09-25 |
Astex Therapeutics Ltd |
3,4-Disubstituted 1H-pyrazole compounds and their use as cyclin dependent kinases (CDK) and glycogen synthase kinase-3 (GSK-3) modulators
|
|
EP1657238A4
(en)
*
|
2003-08-22 |
2008-12-03 |
Takeda Pharmaceutical |
CONDENSATE PYRIMIDINE DERIVATIVE AND ITS USE
|
|
EP1663953A1
(en)
*
|
2003-09-24 |
2006-06-07 |
Methylgene, Inc. |
Inhibitors of histone deacetylase
|
|
GB0322409D0
(en)
*
|
2003-09-25 |
2003-10-29 |
Astrazeneca Ab |
Quinazoline derivatives
|
|
US20050085531A1
(en)
*
|
2003-10-03 |
2005-04-21 |
Hodge Carl N. |
Thiophene-based compounds exhibiting ATP-utilizing enzyme inhibitory activity, and compositions, and uses thereof
|
|
JP4667384B2
(ja)
|
2003-10-07 |
2011-04-13 |
レノビス， インコーポレイテッド |
イオンチャネルリガンドとしてのアミド誘導体および薬学的組成物、ならびにこれらを使用する方法
|
|
US7935724B2
(en)
*
|
2003-10-09 |
2011-05-03 |
Merck Hdac Research, Llc |
Thiophene and benzothiophene hydroxamic acid derivatives
|
|
CA2542329A1
(en)
*
|
2003-10-16 |
2005-04-28 |
Chiron Corporation |
2,6-disubstituted quinazolines, quinoxalines, quinolines and isoquinolines as inhibitors of raf kinase for treatment of cancer
|
|
US20050137234A1
(en)
*
|
2003-12-19 |
2005-06-23 |
Syrrx, Inc. |
Histone deacetylase inhibitors
|
|
WO2005065681A1
(en)
*
|
2003-12-19 |
2005-07-21 |
Takeda San Diego, Inc. |
N- hydroxy-3-(3-(1h-imidazol-2-yl)-phenyl)-acrylamide derivatives and related compounds as histone deacetylase (hdac) inhibitors for the treatment of cancer
|
|
US7592373B2
(en)
|
2003-12-23 |
2009-09-22 |
Boehringer Ingelheim International Gmbh |
Amide compounds with MCH antagonistic activity and medicaments comprising these compounds
|
|
JP2007529422A
(ja)
*
|
2004-01-29 |
2007-10-25 |
エリクシアー ファーマシューティカルズ， インコーポレイテッド |
抗ウイルス治療
|
|
EP1713775A4
(en)
*
|
2004-01-30 |
2009-08-12 |
Smithkline Beecham Corp |
CHEMICAL COMPOUNDS
|
|
SI1725528T1
(sl)
|
2004-03-11 |
2013-11-29 |
4Sc Ag |
Sulfonilpiroli kot HDAC inhibitorji
|
|
KR101258504B1
(ko)
|
2004-03-26 |
2013-04-26 |
메틸진 인코포레이티드 |
히스톤 데아세틸라제의 억제제
|
|
TWI415606B
(zh)
*
|
2004-03-26 |
2013-11-21 |
Methylgene Inc |
組蛋白去乙醯基酶之抑制劑
|
|
US7253204B2
(en)
*
|
2004-03-26 |
2007-08-07 |
Methylgene Inc. |
Inhibitors of histone deacetylase
|
|
EP2543376A1
(en)
|
2004-04-08 |
2013-01-09 |
Targegen, Inc. |
Benzotriazine inhibitors of kinases
|
|
AR050926A1
(es)
*
|
2004-09-03 |
2006-12-06 |
Astrazeneca Ab |
Derivados de benzamida como inhibidores de la histonadesacetilasa(hdac)
|
|
US7776869B2
(en)
|
2004-10-18 |
2010-08-17 |
Amgen Inc. |
Heteroaryl-substituted alkyne compounds and method of use
|
|
WO2006066133A2
(en)
|
2004-12-16 |
2006-06-22 |
Takeda San Diego, Inc. |
Histone deacetylase inhibitors
|
|
GB0501146D0
(en)
*
|
2005-01-20 |
2005-02-23 |
Astrazeneca Ab |
Novel benzamide derivatives
|
|
US8404718B2
(en)
|
2005-01-21 |
2013-03-26 |
Astex Therapeutics Limited |
Combinations of pyrazole kinase inhibitors
|
|
AR054425A1
(es)
|
2005-01-21 |
2007-06-27 |
Astex Therapeutics Ltd |
Sales de adicion de piperidin 4-il- amida de acido 4-(2,6-dicloro-benzoilamino) 1h-pirazol-3-carboxilico.
|
|
BRPI0606110A2
(pt)
*
|
2005-01-25 |
2009-06-02 |
Epix Delaware Inc |
compostos de arilamina substituìdos e seu uso como 5 - ht6 moduladores
|
|
US7576099B2
(en)
|
2005-02-28 |
2009-08-18 |
Renovis, Inc. |
Amide derivatives as ion-channel ligands and pharmaceutical compositions and methods of using the same
|
|
NZ560267A
(en)
|
2005-03-15 |
2010-03-26 |
4Sc Ag |
N-sulphonylpyrroles and their use as histone deacetylase inhibitors
|
|
JP2008536925A
(ja)
|
2005-04-20 |
2008-09-11 |
メルク エンド カムパニー インコーポレーテッド |
ベンゾチオフェンヒドロキサム酸誘導体
|
|
WO2006115833A1
(en)
|
2005-04-20 |
2006-11-02 |
Merck & Co., Inc. |
Benzothiophene hydroxamic acid derivatives with carbamate, urea, amide and sulfonamide substitutions
|
|
WO2006115845A1
(en)
*
|
2005-04-20 |
2006-11-02 |
Merck & Co., Inc. |
Benzothiophene derivatives
|
|
JP2008540574A
(ja)
*
|
2005-05-11 |
2008-11-20 |
タケダ サン ディエゴ インコーポレイテッド |
ヒストンデアセチラーゼ阻害剤
|
|
BRPI0610351A2
(pt)
*
|
2005-05-19 |
2010-06-15 |
Prometic Biosciences Inc |
uso de compostos de triazina e medicamentos compreendendo os mesmos
|
|
BRPI0610322B8
(pt)
|
2005-05-20 |
2021-05-25 |
Methylgene Inc |
inibidores de sinalização de receptor de vegf e de receptor de hgf e composição farmacêutica
|
|
DE102005027274A1
(de)
*
|
2005-06-08 |
2006-12-14 |
Schering Ag |
Inhibitoren der löslichen Adenylatzyklase
|
|
US7417066B2
(en)
|
2005-06-08 |
2008-08-26 |
Schering Ag |
Inhibitors of soluble adenylate cyclase
|
|
WO2006138304A2
(en)
|
2005-06-14 |
2006-12-28 |
Taigen Biotechnology |
Pyrimidine compounds
|
|
US8193206B2
(en)
|
2005-06-14 |
2012-06-05 |
Taigen Biotechnology Co., Ltd. |
Pyrimidine compounds
|
|
JP4528918B2
(ja)
*
|
2005-06-21 |
2010-08-25 |
学校法人 関西大学 |
カルボキサミド誘導体
|
|
EP1896395B1
(en)
|
2005-06-24 |
2015-07-15 |
Merck Sharp & Dohme Corp. |
Modified malonate derivatives
|
|
US7732475B2
(en)
*
|
2005-07-14 |
2010-06-08 |
Takeda San Diego, Inc. |
Histone deacetylase inhibitors
|
|
EP2258358A3
(en)
|
2005-08-26 |
2011-09-07 |
Braincells, Inc. |
Neurogenesis with acetylcholinesterase inhibitor
|
|
US7678363B2
(en)
|
2005-08-26 |
2010-03-16 |
Braincells Inc |
Methods of treating psychiatric conditions comprising administration of muscarinic agents in combination with SSRIs
|
|
PL1928872T3
(pl)
|
2005-09-21 |
2012-08-31 |
4Sc Ag |
Nowe sulfonylopirole jako inhibitory HDAC
|
|
NZ566073A
(en)
|
2005-09-21 |
2011-08-26 |
4Sc Ag |
Sulphonylpyrrole hydrochloride salts as histone deacetylases inhibitors
|
|
GB0521244D0
(en)
|
2005-10-19 |
2005-11-30 |
Astrazeneca Ab |
Benzamide compounds
|
|
EP2377530A3
(en)
|
2005-10-21 |
2012-06-20 |
Braincells, Inc. |
Modulation of neurogenesis by PDE inhibition
|
|
EP1942879A1
(en)
|
2005-10-31 |
2008-07-16 |
Braincells, Inc. |
Gaba receptor mediated modulation of neurogenesis
|
|
DK1951684T3
(en)
|
2005-11-01 |
2016-10-24 |
Targegen Inc |
BIARYLMETAPYRIMIDIN kinase inhibitors
|
|
US8217042B2
(en)
|
2005-11-11 |
2012-07-10 |
Zentaris Gmbh |
Pyridopyrazines and their use as modulators of kinases
|
|
AU2006313701B2
(en)
|
2005-11-11 |
2012-05-31 |
Aeterna Zentaris Gmbh |
Novel pyridopyrazines and their use as modulators of kinases
|
|
EP1790342A1
(de)
|
2005-11-11 |
2007-05-30 |
Zentaris GmbH |
Pyridopyrazin-Derivate und deren Verwendung als Modulatoren der Signaltransduktionswege
|
|
AR057579A1
(es)
|
2005-11-23 |
2007-12-05 |
Merck & Co Inc |
Compuestos espirociclicos como inhibidores de histona de acetilasa (hdac)
|
|
WO2007100657A2
(en)
|
2006-02-28 |
2007-09-07 |
Merck & Co., Inc. |
Inhibitors of histone deacetylase
|
|
US20100216734A1
(en)
|
2006-03-08 |
2010-08-26 |
Braincells, Inc. |
Modulation of neurogenesis by nootropic agents
|
|
CA2648804C
(en)
|
2006-04-07 |
2014-05-27 |
Methylgene Inc. |
Benzamide derivatives as inhibitors of histone deacetylase
|
|
EP2013196B1
(en)
*
|
2006-04-26 |
2015-09-16 |
Merck Sharp & Dohme Corp. |
Disubstituted aniline compounds
|
|
WO2007134136A2
(en)
|
2006-05-09 |
2007-11-22 |
Braincells, Inc. |
Neurogenesis by modulating angiotensin
|
|
US7678808B2
(en)
|
2006-05-09 |
2010-03-16 |
Braincells, Inc. |
5 HT receptor mediated neurogenesis
|
|
US8119652B2
(en)
|
2006-05-18 |
2012-02-21 |
Merck Sharp & Dohme Corp. |
Aryl-fused spirocyclic compounds
|
|
JP2009544611A
(ja)
|
2006-07-20 |
2009-12-17 |
メルク エンド カムパニー インコーポレーテッド |
ヒストン脱アセチル化酵素阻害剤としてのリン誘導体
|
|
AU2007292848A1
(en)
|
2006-09-08 |
2008-03-13 |
Braincells, Inc. |
Combinations containing a 4-acylaminopyridine derivative
|
|
US20100184806A1
(en)
|
2006-09-19 |
2010-07-22 |
Braincells, Inc. |
Modulation of neurogenesis by ppar agents
|
|
RU2459811C2
(ru)
|
2006-10-28 |
2012-08-27 |
Метилджен Инк. |
Ингибиторы гистоновой деацетилазы
|
|
WO2008076883A2
(en)
|
2006-12-15 |
2008-06-26 |
Abraxis Bioscience, Inc. |
Triazine derivatives and their therapeutical applications
|
|
WO2008104869A1
(en)
|
2007-02-26 |
2008-09-04 |
Pfizer Products Inc. |
Nicotinamide derivatives as inhibitors of h-pgds and their use for treating prostaglandin d2 mediated diseases
|
|
US8030344B2
(en)
*
|
2007-03-13 |
2011-10-04 |
Methylgene Inc. |
Inhibitors of histone deacetylase
|
|
EP2170076B1
(en)
|
2007-06-27 |
2016-05-18 |
Merck Sharp & Dohme Corp. |
4-carboxybenzylamino derivatives as histone deacetylase inhibitors
|
|
WO2009005638A2
(en)
|
2007-06-27 |
2009-01-08 |
Merck & Co., Inc. |
Pyridyl and pyrimidinyl derivatives as histone deacetylase inhibitors
|
|
AU2008300827B2
(en)
|
2007-09-19 |
2013-04-04 |
4Sc Ag |
Novel tetrahydrofusedpyridines as histone deacetylase inhibitors
|
|
JP5322477B2
(ja)
*
|
2007-09-28 |
2013-10-23 |
富士フイルム株式会社 |
新規アセチレン化合物、その塩、その製造方法、それを構成単位として含むポリマー、該ポリマーの製造方法、該ポリマーの組成物、該ポリマー組成物を硬化させてなる硬化物
|
|
BRPI0817245A2
(pt)
*
|
2007-09-27 |
2015-06-16 |
Hoffmann La Roche |
Derivados e quinolina como antagonistas receptores de 5ht5a
|
|
JP2011501746A
(ja)
*
|
2007-10-10 |
2011-01-13 |
オーキッド リサーチ ラボラトリーズ リミテッド |
新規ヒストンデアセチラーゼインヒビター
|
|
RU2453536C2
(ru)
*
|
2007-10-22 |
2012-06-20 |
Оркид Рисерч Лабораториз Лимитед |
Ингибиторы гистондезацетилазы
|
|
EP2060565A1
(en)
*
|
2007-11-16 |
2009-05-20 |
4Sc Ag |
Novel bifunctional compounds which inhibit protein kinases and histone deacetylases
|
|
CN101925573A
(zh)
*
|
2008-01-29 |
2010-12-22 |
霍夫曼-拉罗奇有限公司 |
新型的n-(2-氨基-苯基)-酰胺衍生物
|
|
PT2268635E
(pt)
|
2008-04-21 |
2015-10-06 |
Taigen Biotechnology Co Ltd |
Compostos heterocíclicos
|
|
CN102026969A
(zh)
*
|
2008-05-16 |
2011-04-20 |
霍夫曼-拉罗奇有限公司 |
新型的n-(2-氨基-苯基)-丙烯酰胺类
|
|
NZ588511A
(en)
|
2008-05-23 |
2012-04-27 |
Novartis Ag |
Derivatives of quinolines and quinoxalines as protein tyrosine kinase inhibitors
|
|
ES2389754T3
(es)
|
2008-05-23 |
2012-10-31 |
Santen Pharmaceutical Co., Ltd |
Nuevos derivados de tiofendiamina con estructura urea
|
|
EP2303862B1
(en)
|
2008-05-27 |
2016-08-24 |
The Board of Regents of The University of Texas System |
Wnt protein signalling inhibitors
|
|
AU2009289649B2
(en)
|
2008-09-03 |
2016-05-05 |
Biomarin Pharmaceutical Inc. |
Compositions including 6-aminohexanoic acid derivatives as HDAC inhibitors
|
|
US8202866B2
(en)
*
|
2008-09-17 |
2012-06-19 |
Hoffmann-La Roche Inc. |
Ortho-aminoanilides for the treatment of cancer
|
|
CN106243100B
(zh)
*
|
2008-10-10 |
2019-04-09 |
Vm生物医药公司 |
治疗酒精使用障碍，疼痛和其他疾病的药物组合与方法
|
|
WO2010045095A1
(en)
|
2008-10-14 |
2010-04-22 |
Ning Xi |
Compounds and methods of use
|
|
US9023834B2
(en)
|
2008-11-13 |
2015-05-05 |
Taigen Biotechnology Co., Ltd. |
Lyophilization formulation
|
|
EP3725775A1
(en)
|
2009-02-17 |
2020-10-21 |
Syntrix Biosystems, Inc. |
Pyridine- and pyrimidinecarboxamides as cxcr2 modulators
|
|
US20100216805A1
(en)
|
2009-02-25 |
2010-08-26 |
Braincells, Inc. |
Modulation of neurogenesis using d-cycloserine combinations
|
|
CN101906076B
(zh)
*
|
2009-06-04 |
2013-03-13 |
深圳微芯生物科技有限责任公司 |
作为蛋白激酶抑制剂和组蛋白去乙酰化酶抑制剂的萘酰胺衍生物、其制备方法及应用
|
|
CA2765044A1
(en)
|
2009-06-09 |
2010-12-16 |
California Capital Equity, Llc |
Benzyl substituted triazine derivatives and their therapeutical applications
|
|
AU2010258974A1
(en)
*
|
2009-06-09 |
2012-01-12 |
California Capital Equity, Llc |
Pyridil-triazine inhibitors of hedgehog signaling
|
|
CN102573480B
(zh)
|
2009-06-09 |
2015-06-10 |
加利福尼亚资本权益有限责任公司 |
三嗪衍生物及其治疗应用
|
|
US8784873B2
(en)
*
|
2009-07-22 |
2014-07-22 |
Naturewise Biotech & Medicals Corporation |
Use of histone deacetylase inhibitors in changing MRJP3 protein in royal jelly
|
|
JP2011057661A
(ja)
*
|
2009-08-14 |
2011-03-24 |
Bayer Cropscience Ag |
殺虫性カルボキサミド類
|
|
CA2779497A1
(en)
|
2009-10-30 |
2011-05-05 |
Massachusetts Institute Of Technology |
The use of ci-994 and dinaline for the treatment of memory/cognition and anxiety disorders
|
|
US8927547B2
(en)
|
2010-05-21 |
2015-01-06 |
Noviga Research Ab |
Pyrimidine derivatives
|
|
US8779149B2
(en)
|
2010-08-23 |
2014-07-15 |
Syntrix Biosystems, Inc. |
Aminopyridine- and aminopyrimidinecarboxamides as CXCR2 modulators
|
|
AU2010363329A1
(en)
|
2010-11-07 |
2013-05-09 |
Targegen, Inc. |
Compositions and methods for treating myelofibrosis
|
|
WO2012118632A1
(en)
|
2011-02-28 |
2012-09-07 |
Ning Xi |
Substituted quinoline compounds and methods of use
|
|
US10059723B2
(en)
|
2011-02-28 |
2018-08-28 |
Biomarin Pharmaceutical Inc. |
Histone deacetylase inhibitors
|
|
US8957066B2
(en)
|
2011-02-28 |
2015-02-17 |
Biomarin Pharmaceutical Inc. |
Histone deacetylase inhibitors
|
|
JP6250403B2
(ja)
*
|
2011-02-28 |
2017-12-20 |
バイオマリン ファーマシューティカル インク |
ヒストン脱アセチル化酵素阻害剤
|
|
AU2012230229A1
(en)
|
2011-03-24 |
2013-10-10 |
Noviga Research Ab |
Novel pyrimidine derivatives
|
|
EP2508184A1
(en)
|
2011-04-06 |
2012-10-10 |
Æterna Zentaris GmbH |
Pyridopyrazine derivatives and their use
|
|
CN102775356B
(zh)
*
|
2011-05-13 |
2015-07-22 |
江苏恒谊药业有限公司 |
4-氨基喹唑啉衍生物及其应用
|
|
CN102807526B
(zh)
*
|
2011-06-21 |
2015-12-02 |
寿光富康制药有限公司 |
组蛋白去乙酰化酶抑制剂ZYJ-D08a及其差向异构体的制备方法与应用
|
|
CN102838625B
(zh)
*
|
2011-06-22 |
2015-04-15 |
中国科学院上海药物研究所 |
四氢吡啶并噻唑类化合物、其制备方法、包含该化合物的药物组合物及其用途
|
|
CN102276554B
(zh)
*
|
2011-06-28 |
2013-10-30 |
四川大学 |
4-（（2-氨基-5-巯基-1,3,4-噻二唑）-甲基）-苯甲酰胺衍生物及其制备方法和用途
|
|
BR112014000371A2
(pt)
*
|
2011-07-08 |
2017-01-10 |
Novartis Ag |
derivados de trifluormetil-oxadiazol e uso dos mesmos no tratamento de doença
|
|
CA2842364A1
(en)
*
|
2011-07-29 |
2013-02-07 |
Karyopharm Therapeutics, Inc. |
Nuclear transport modulators and uses thereof
|
|
ES2655645T3
(es)
|
2011-07-29 |
2018-02-21 |
Karyopharm Therapeutics, Inc. |
Moduladores de transporte nuclear que contienen hidrazida y usos de los mismos
|
|
MX2014006409A
(es)
*
|
2011-11-28 |
2014-07-30 |
Novartis Ag |
Novedosos derivados de trifluoro-metil-oxadiazol y su uso en el tratamiento de enfermedades.
|
|
JP5881460B2
(ja)
*
|
2012-02-23 |
2016-03-09 |
公立大学法人名古屋市立大学 |
新規アミド化合物及びその用途
|
|
WO2013137371A1
(ja)
*
|
2012-03-15 |
2013-09-19 |
興和株式会社 |
新規ピリミジン化合物及びそれらを含有する医薬
|
|
PL3404027T3
(pl)
|
2012-05-09 |
2020-09-21 |
Biogen Ma Inc. |
Modulatory transportu jądrowego i ich zastosowania
|
|
WO2013184806A1
(en)
|
2012-06-05 |
2013-12-12 |
University Of Kansas |
Inhibitors of respiratory syncytial virus
|
|
AU2013296897B2
(en)
|
2012-07-28 |
2015-09-17 |
Beijing Findcure Biosciences Ltd. |
Substituted pyrazolone compounds and methods of use
|
|
TWI574962B
(zh)
|
2012-11-14 |
2017-03-21 |
加拓科學公司 |
作爲ｐｉ３激酶調節劑的芳雜環化合物及其使用方法和用途
|
|
ES2718495T3
(es)
|
2012-12-21 |
2019-07-02 |
Celgene Quanticel Res Inc |
Inhibidores de la histona desmetilasa
|
|
JP2016511237A
(ja)
|
2013-02-01 |
2016-04-14 |
アセチロン ファーマシューティカルズ インコーポレイテッドＡｃｅｔｙｌｏｎ Ｐｈａｒｍａｃｅｕｔｉｃａｌｓ，Ｉｎｃ． |
選択的ｈｄａｃ３阻害剤
|
|
US9139583B2
(en)
|
2013-02-01 |
2015-09-22 |
Acetylon Pharmaceuticals, Inc. |
Selective HDAC3 inhibitors
|
|
BR112015018318A2
(pt)
|
2013-02-21 |
2017-08-22 |
Sunshine Lake Pharma Co Ltd |
Composto, composição farmacêutica, uso de um composto ou de uma composição farmacêutica, e, métodos para prevenir, gerenciar, tratar ou diminuir a severidade de um distúrbio proliferativo em um paciente e para inibir ou modular a atividade de uma proteína quinase em uma amostra biológica
|
|
WO2014144772A1
(en)
|
2013-03-15 |
2014-09-18 |
Karyopharm Therapeutics Inc. |
Methods of promoting wound healing using crm1 inhibitors
|
|
JP6503338B2
(ja)
|
2013-03-15 |
2019-04-17 |
バイオマリン ファーマシューティカル インコーポレイテッド |
Ｈｄａｃ阻害剤
|
|
LT3010892T
(lt)
|
2013-06-21 |
2019-04-10 |
Karyopharm Therapeutics Inc. |
1,2,4-triazolai kaip branduolio transporto moduliatoriai ir jų panaudojimas
|
|
US8969365B2
(en)
|
2013-08-02 |
2015-03-03 |
Syntrix Biosystems, Inc. |
Thiopyrimidinecarboxamides as CXCR1/2 modulators
|
|
US10561676B2
(en)
|
2013-08-02 |
2020-02-18 |
Syntrix Biosystems Inc. |
Method for treating cancer using dual antagonists of CXCR1 and CXCR2
|
|
US10046002B2
(en)
|
2013-08-02 |
2018-08-14 |
Syntrix Biosystems Inc. |
Method for treating cancer using chemokine antagonists
|
|
EP2853532B1
(en)
*
|
2013-09-28 |
2020-12-09 |
Instytut Farmakologii Polskiej Akademii Nauk |
1,2,4-oxadiazole derivatives as allosteric modulators of metabotropic glutamate receptors belonging to group III
|
|
SG10201704327RA
(en)
|
2013-10-14 |
2017-06-29 |
Eisai R&D Man Co Ltd |
Selectively substituted quinoline compounds
|
|
MX363708B
(es)
|
2013-10-14 |
2019-03-29 |
Eisai R&D Man Co Ltd |
Compuestos de quinolina selectivamente sustituidos.
|
|
EP3769757A3
(en)
*
|
2013-10-18 |
2021-10-06 |
The General Hospital Corporation |
Imaging histone deacetylases with a radiotracer using positron emission tomography
|
|
WO2015069693A1
(en)
*
|
2013-11-05 |
2015-05-14 |
Dana-Farber Cancer Institute, Inc. |
Inhibitors of histone deacetylase
|
|
US9636298B2
(en)
|
2014-01-17 |
2017-05-02 |
Methylgene Inc. |
Prodrugs of compounds that enhance antifungal activity and compositions of said prodrugs
|
|
SG11201610813TA
(en)
|
2014-06-25 |
2017-01-27 |
Quanticel Pharmaceuticals Inc |
Histone demethylase inhibitors
|
|
AU2015295248B2
(en)
*
|
2014-07-31 |
2019-05-16 |
Institut Pasteur Korea |
2-amino-benzimidazole derivatives and their use as 5-lipoxygenase and/or prostaglandin e synthase inhibitors
|
|
DK3180331T3
(da)
|
2014-08-15 |
2022-09-12 |
Karyopharm Therapeutics Inc |
Polymorfer af selinexor
|
|
KR20180022840A
(ko)
*
|
2015-07-02 |
2018-03-06 |
바이오마린 파머수티컬 인크. |
히스톤 데아세틸라제 저해제
|
|
EP3365344B1
(en)
|
2015-10-19 |
2020-12-09 |
Sunshine Lake Pharma Co., Ltd. |
(3-chloro-4-fluoro-phenyl)-(6-((4ar,7as)-3-(hexahydro-(1,4)dioxino(2,3-c)pyrrol-6-yl)-propoxy)-7-methoxy-quinazolin-4-yl)-amine di(methanesulfonic acid) salt and crystalline form of the monohydrate (a egfr inhibitor)
|
|
EP3397633A1
(en)
|
2015-12-31 |
2018-11-07 |
Karyopharm Therapeutics, Inc. |
Nuclear transport modulators and uses thereof
|
|
MA43530A
(fr)
|
2015-12-31 |
2018-11-07 |
Karyopharm Therapeutics Inc |
Modulateurs de transport nucléaire et leurs utilisations
|
|
KR102379959B1
(ko)
|
2016-05-12 |
2022-03-29 |
난징 스치 파마슈티컬 코포레이션 리미티드 |
신규 2,4,6-트리치환된-s-트리아진 화합물, 그 제조방법 및 용도
|
|
CN106242992A
(zh)
*
|
2016-07-25 |
2016-12-21 |
北京化工大学 |
一种苯甲酰胺类化合物及其在制备抑制癌细胞增殖和/或治疗癌症的药物中的应用
|
|
CN106496053B
(zh)
*
|
2016-09-22 |
2018-01-05 |
潍坊医学院 |
一种组蛋白去乙酰酶抑制剂n‑(2’‑胺基苯基)‑4‑(双(2‑氯乙基)胺基)苯甲酰胺及其制备方法和应用
|
|
US10660909B2
(en)
|
2016-11-17 |
2020-05-26 |
Syntrix Biosystems Inc. |
Method for treating cancer using chemokine antagonists
|
|
WO2018098472A1
(en)
|
2016-11-28 |
2018-05-31 |
Karyopharm Therapeutics Inc. |
Crm1 inhibitors for treating epilepsy
|
|
TW201829381A
(zh)
*
|
2016-12-22 |
2018-08-16 |
美商拜奧馬林製藥公司 |
組蛋白脫乙醯基酶抑制劑
|
|
WO2018165520A1
(en)
|
2017-03-10 |
2018-09-13 |
Vps-3, Inc. |
Metalloenzyme inhibitor compounds
|
|
CN107141244B
(zh)
*
|
2017-05-08 |
2019-11-19 |
潍坊医学院 |
吲哚丁酸类组蛋白去乙酰酶抑制剂及其制备方法和应用
|
|
US11535598B2
(en)
*
|
2017-05-16 |
2022-12-27 |
Annji Pharmaceutical Co., Ltd. |
Histone deacetylases (HDACs) inhibitors
|
|
US11230524B2
(en)
*
|
2017-08-17 |
2022-01-25 |
Standard Llc |
Myocyte enhancer factor 2 (MEF2) modulators
|
|
CN107459480A
(zh)
*
|
2017-09-05 |
2017-12-12 |
镇江斯格派医疗器械有限公司 |
一种双芳基脲类组蛋白去乙酰化酶抑制剂
|
|
KR101964810B1
(ko)
|
2017-10-12 |
2019-04-02 |
충북대학교 산학협력단 |
Hdac 억제제로서 신규한 퀴나졸린-4(3h)-원 기반 n-하이드록시벤즈아미드 또는 n-하이드록시프로펜아미드 및 이를 유효성분으로 포함하는 항암제 조성물
|
|
US12133852B2
(en)
|
2017-11-15 |
2024-11-05 |
Epivario, Inc. |
ACSS2 inhibitors and methods of use thereof
|
|
BR112020009729A2
(pt)
|
2017-11-15 |
2020-11-03 |
Metabomed Ltd. |
inibidores de acss2 e métodos de uso dos mesmos
|
|
CN108570012B
(zh)
*
|
2018-05-23 |
2021-11-12 |
中南大学 |
1,3-苯并噁嗪-2,4(3h)-二酮衍生物及其合成方法和用途
|
|
CN109020951B
(zh)
*
|
2018-08-24 |
2020-06-02 |
大连理工大学 |
含三取代三聚氯氰的萘酰亚胺类衍生物及其合成方法和应用
|
|
CN110078722A
(zh)
*
|
2018-10-31 |
2019-08-02 |
南京先进生物材料与过程装备研究院有限公司 |
一种噻吨酮类stat3抑制剂马来酸盐晶型a及其应用
|
|
CN109336870A
(zh)
*
|
2018-10-31 |
2019-02-15 |
南京先进生物材料与过程装备研究院有限公司 |
咔唑类stat3抑制剂晶型i及其制备方法
|
|
CN109336867A
(zh)
*
|
2018-10-31 |
2019-02-15 |
南京先进生物材料与过程装备研究院有限公司 |
咔唑类stat3抑制剂晶型a及其制备方法
|
|
CN109369626A
(zh)
*
|
2018-10-31 |
2019-02-22 |
南京先进生物材料与过程装备研究院有限公司 |
咔唑类stat3抑制剂p晶型及其制备方法
|
|
CN109293647A
(zh)
*
|
2018-10-31 |
2019-02-01 |
南京先进生物材料与过程装备研究院有限公司 |
二苯并[b,d]噻吩类STAT3抑制剂的M晶型及其制备方法
|
|
CN109369628A
(zh)
*
|
2018-10-31 |
2019-02-22 |
南京先进生物材料与过程装备研究院有限公司 |
咔唑类stat3抑制剂晶型ii及其制备方法
|
|
CN109336869A
(zh)
*
|
2018-10-31 |
2019-02-15 |
南京先进生物材料与过程装备研究院有限公司 |
一种stat3抑制剂的甲磺酸盐及其制备方法与用途
|
|
CN109336877A
(zh)
*
|
2018-10-31 |
2019-02-15 |
南京先进生物材料与过程装备研究院有限公司 |
二苯并[b,d]噻吩类STAT3抑制剂的甲磺酸盐及其制备方法与用途
|
|
CN109336876A
(zh)
*
|
2018-10-31 |
2019-02-15 |
南京先进生物材料与过程装备研究院有限公司 |
二苯并[b,d]噻吩类STAT3抑制剂的酒石酸盐及其制备方法与用途
|
|
CN109180656A
(zh)
*
|
2018-10-31 |
2019-01-11 |
南京先进生物材料与过程装备研究院有限公司 |
一类stat3抑制剂及其应用
|
|
CN109336871A
(zh)
*
|
2018-10-31 |
2019-02-15 |
南京先进生物材料与过程装备研究院有限公司 |
一种stat3抑制剂的马来酸盐及其制备方法与用途
|
|
CN114008025A
(zh)
|
2019-05-14 |
2022-02-01 |
美特波米德有限公司 |
Acss2抑制剂和其使用方法
|
|
GB201918404D0
(en)
*
|
2019-12-13 |
2020-01-29 |
Z Factor Ltd |
Compounds and their use for the treatment of aplha1-antitrypsin deficiency
|
|
CN111116469A
(zh)
*
|
2019-12-27 |
2020-05-08 |
北京鑫开元医药科技有限公司 |
一种hdac抑制剂、制备方法、药物组合物及其用途
|
|
CN113549057B
(zh)
*
|
2020-04-24 |
2023-01-31 |
中国药科大学 |
Snail抑制剂及其衍生物，制备方法、药物组合物和应用
|
|
CN115403483B
(zh)
*
|
2021-07-02 |
2024-01-26 |
河南省儿童医院郑州儿童医院 |
含二苯乙烯或二苯甲酮骨架的ca-4衍生物、药物组合物及其制备方法和应用
|
|
CN114539180B
(zh)
*
|
2021-12-24 |
2025-02-07 |
贵州大学 |
一种含异噁唑啉的双酰胺类化合物及其制备方法和用途
|
|
CN118745163A
(zh)
*
|
2024-06-06 |
2024-10-08 |
四川省医学科学院·四川省人民医院 |
苯并呋喃类化合物、其制备方法及其应用和pdgfr激酶抑制剂
|